Avelumab Program Rollover Study
Clinical trial NCT03815643 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03815643
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-22
- Primary completion
- 2026-08-21
- Enrollment
- 205
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.